Detalhe da pesquisa
1.
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
J Biol Chem
; 296: 100150, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277363
2.
Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.
Brain
; 144(10): 2985-2993, 2021 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993268
3.
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
Dis Model Mech
; 16(1)2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511140
4.
AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
Neurotherapeutics
; 19(3): 982-993, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347645
5.
The antioxidant MnTBAP does not effectively downregulate CD4 expression in T cells in vivo.
J Neuroimmunol
; 354: 577544, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756414
6.
Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.
Neurotherapeutics
; 18(2): 1414-1425, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830476